We are live on ! Find out more
SCM

Suvretta Capital Management Portfolio holdings

AUM $3.92B
1-Year Est. Return 86.67%
This Fund
S&P 500
This Quarter Est. Return
+0.32%
1 Year Est. Return
+86.67%
3 Year Est. Return
+295.96%
5 Year Est. Return
+364.48%
10 Year Est. Return
+2,073.65%
AUM
$5.94B
AUM Growth
-$751M
Cap. Flow
-$607M
Cap. Flow %
-10.22%
Top 10 Hldgs %
40.52%
Holding
146
New
24
Increased
39
Reduced
15
Closed
40

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$179M
2
ALIT icon
Alight
ALIT
+$88M
3
XYZ
Block Inc
XYZ
+$77.8M
4
TWLO icon
Twilio
TWLO
+$73.7M
5
WRBY icon
Warby Parker
WRBY
+$53.8M

Top Sells

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$269M
2
UBER icon
Uber
UBER
+$193M
3
META icon
Meta Platforms (Facebook)
META
+$161M
4
PSFE icon
Paysafe
PSFE
+$156M
5
AAPL icon
Apple
AAPL
+$99.6M

Sector Composition

Rank Sector Weight
1 Healthcare 32.32%
2 Consumer Discretionary 19.04%
3 Technology 18.49%
4 Industrials 18.23%
5 Financials 4.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FRSH icon
76
Freshworks
FRSH
$3.27B
$6.4M 0.11%
+150,000
New +$6.72M
IMRX icon
77
Immuneering
IMRX
$292M
$5.31M 0.09%
+200,000
New +$5.37M
NEXI
78
DELISTED
NexImmune, Inc. Common Stock
NEXI
$5.21M 0.09%
13,769
-861
-6% -$289K
RACB
79
DELISTED
Research Alliance Corp. II Class A Common Stock
RACB
$4.92M 0.08%
500,000
– –
MIST icon
80
Milestone Pharmaceuticals
MIST
$152M
$4.86M 0.08%
851,291
– –
MAAC
81
DELISTED
Montes Archimedes Acquisition Corp. Class A Common Stock
MAAC
$4.67M 0.08%
+500,000
New +$4.96M
OTIC
82
DELISTED
Otonomy, Inc.
OTIC
$4.58M 0.08%
2,387,700
– –
NUVL
83
DELISTED
Nuvalent
NUVL
$4.51M 0.08%
+200,000
New +$5.8M
PRDS
84
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$3.98M 0.07%
400,000
– –
ORIC icon
85
Oric Pharmaceuticals
ORIC
$1.4B
$3.12M 0.05%
+149,100
New +$3.02M
HCAQ
86
DELISTED
HealthCor Catalio Acquisition Corp. Class A Ordinary Shares
HCAQ
$2.97M 0.05%
300,000
– –
OMEG
87
DELISTED
Omega Alpha SPAC Class A Ordinary Shares
OMEG
$2.92M 0.05%
300,000
– –
EBAC
88
DELISTED
European Biotech Acquisition Corp. Class A Ordinary Shares
EBAC
$2.9M 0.05%
300,000
– –
CANO.WS
89
DELISTED
Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150
CANO.WS
$2.79M 0.05%
674,566
– –
BNTC icon
90
Benitec Biopharma
BNTC
$468M
$2.75M 0.05%
45,235
– –
VLTA
91
DELISTED
Volta Inc.
VLTA
$2.6M 0.04%
+300,000
New +$3.08M
ALIT.WS
92
DELISTED
Alight Inc Warrants
ALIT.WS
$2.36M 0.04%
+774,375
New +$1.93M
DBTX
93
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
$2.03M 0.03%
263,600
– –
BLSA
94
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
$1.99M 0.03%
200,000
– –
TMPM
95
DELISTED
Turmeric Acquisition Corp. Class A Ordinary Shares
TMPM
$1.96M 0.03%
200,000
– –
NAUT icon
96
Nautilus Biotechnolgy
NAUT
$115M
$1.93M 0.03%
314,835
– –
FHTX icon
97
Foghorn Therapeutics
FHTX
$360M
$1.17M 0.02%
84,000
– –
EUCR
98
DELISTED
Eucrates Biomedical Acquisition Corp. Ordinary Shares
EUCR
$978K 0.02%
99,999
– –
FLAC
99
DELISTED
Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares
FLAC
$859K 0.01%
87,498
– –
ADAG
100
Adagene
ADAG
$272M
$614K 0.01%
42,722
-161,278
-79% -$2.64M
2 3
4
5 6

Similar funds

MIM
Meridiem Investment Management London, United Kingdom $3.92B AUM 1.64% 1-Year Est. Return
BCP
BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return
AS
American Securities New York $3.93B AUM 52.22% 1-Year Est. Return
MSI
Mitsui Sumitomo Insurance Tokyo, Japan $3.9B AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
LWCA
Locust Wood Capital Advisers New York $3.95B AUM 33.1% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return

Suvretta Capital Management's Q3 2021 Portfolio in Review

As of Q3 2021, Suvretta Capital Management held 146 positions worth $5.94B, down 11% from $6.69B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Suvretta Capital Management withdrew a net $607M in Q3 2021, closing 40 positions and reducing 15 holdings. Its most notable exit was Alphabet (Google) Class C, an estimated $269M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, Suvretta Capital Management opened a new position in Thermo Fisher Scientific worth $186M.

  • Suvretta Capital Management's largest Q3 2021 buy was Thermo Fisher Scientific: 325,810 shares worth $186M.
  • Suvretta Capital Management added most to Twilio in Q3 2021, an estimated $73.7M increase.
  • Suvretta Capital Management's biggest Q3 2021 reduction was Medtronic, cutting an estimated $50.1M.
  • Suvretta Capital Management fully exited Alphabet (Google) Class C in Q3 2021, selling an estimated $269M.
  • Suvretta Capital Management's ten largest holdings make up 41% of its $5.94B portfolio in Q3 2021.
  • Suvretta Capital Management opened 24 new positions and closed 40 in Q3 2021.
  • Suvretta Capital Management's portfolio value fell 11% quarter-over-quarter to $5.94B.

Based on Suvretta Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.